Financial Performance - In Q3 2024, the company achieved a revenue of 755 million CNY, representing a year-on-year growth of 14.18% [1] - The net profit attributable to shareholders reached 74.39 million CNY, a significant increase of 236.47% [1] - The net profit after deducting non-recurring gains and losses was 58.30 million CNY, showing a remarkable growth of 523.41% [1] Business Segments - The industrial products segment (intermediates and active ingredients) faced fluctuations in gross margins due to supply-demand dynamics and intense competition, but has shown signs of recovery with some product prices rebounding [2] - The formulation business has been steadily increasing, focusing on differentiated strategies and enhancing brand building, which is reflected in the improved financial results [2] Market Dynamics - The rise of the Indian agrochemical industry poses some competitive pressure on the Chinese market, but the impact on the company is currently minimal due to its focus on domestic market expansion and core product areas [2] - The company has a long-term development plan for its core product, Bising® (Thiazole Zinc), aiming for significant brand influence in overseas markets, with product registrations ongoing in 11 countries [2] Strategic Initiatives - The company is actively enhancing its capabilities to expand into overseas markets, focusing on product registration, patent protection, and customer engagement [3] - In the field of biopesticides, the company has established a dedicated R&D team and launched two biopesticide products, with plans for continued innovation and development in this area [3]
新农股份(002942) - 新农股份投资者关系管理信息